Orion S.A. (OEC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Annual General Meeting scheduled for June 25, 2026, with both physical and virtual attendance options; record date is April 23, 2026.
Agenda includes election of eight directors, approval of board and executive compensation, financial statements, allocation of results, discharge of directors and auditor, and auditor appointments.
Company operates globally in specialty chemicals, focusing on carbon black, with $1.8 billion in net revenue and a strong sustainability mission.
2025 financials show resilience amid industry challenges: net sales down 4%, adjusted EBITDA down 18%, but positive free cash flow of $55 million and improved plant reliability.
Achieved second-best safety performance in company history and received multiple industry safety awards.
Voting matters and shareholder proposals
Shareholders will vote on director elections, board and executive compensation (including say-on-pay and frequency), approval of annual and consolidated accounts, allocation of results and dividends, discharge of directors and auditor, and auditor appointments.
Board recommends voting for all proposals and for annual say-on-pay votes.
Shareholders holding at least 10% of shares may add agenda items or propose director nominations.
Board of directors and corporate governance
Board consists of eight nominees (seven independent, one CEO), with diverse backgrounds in leadership, finance, operations, and sustainability.
Board refreshment ongoing: five new independent directors added in six years; focus on diversity, independence, and global experience.
Board committees: Audit, Compensation, and Nominating/Sustainability/Governance, each with defined risk oversight roles.
Annual board and committee evaluations, robust governance guidelines, and regular strategy and risk reviews.
Latest events from Orion S.A.
- Q2 2026 net sales up 7%; Specialty segment drives sequential EBITDA growth and outlook raised.OEC
Q2 2026 - EU supply bans and shipping disruptions set up a strong 2025 outlook amid rising free cash flow.OEC
Jefferies Global Industrial Conference 2024 - Strong shareholder support for all proposals amid challenging market conditions and operational progress.OEC
AGM 2026 - Q1 2026 Adjusted EBITDA beat expectations; 2026 guidance raised despite net loss.OEC
Q1 2026 - Proxy covers director elections, pay, audit, risk, and ESG, with strong governance focus.OEC
Proxy filing - 2025 saw resilient cash flow, margin stability, and strengthened market leadership in carbon black.OEC
Investor presentation - 2025 earnings fell but free cash flow stayed positive; 2026 outlook remains cautious.OEC
Q4 2025 - Adjusted EBITDA grew 4% YoY despite fraud losses, with improved 2025 free cash flow expected.OEC
Q3 2024 - Commercialization of a unique molecule and free cash flow inflection expected by 2026.OEC
Gabelli Funds' 16th Annual Specialty Chemicals Symposium